PB0055 Influence of Argatroban on Fibrinolysis ex-vivo in Blood Samples of Healthy Volunteers and in-vivo in Critically ill COVID-19 Patients
Mirjam Bachler(Innsbruck Medical University), D Friès(Innsbruck Medical University), Volker Schäfer(Goethe University Frankfurt), Raoul Kammerlander, A. Tobiasch(Innsbruck Medical University), K. Pezzi, Michael Joannidis(Innsbruck Medical University), J. Bösch, Daniel Niederbrunner(Innsbruck Medical University)
Cited by 0
Related Papers
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
|New England Journal of Medicine|2021|979
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
|Intensive Care Medicine|2009|906
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823